This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $142,843.00 firm-fixed-price purchase order to Hesperos, Inc., a leading company in organ-on-a-chip technology, to provide scientific testing services. The contract is for the target validation and therapeutic evaluation of drug compound TRND00601748-01 in NGLY1 deficient cell-based models, including motoneurons and neuromuscular junction models. This...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Emulate Inc., a for-profit small business organization. The contract, valued at $24,997.00, is for the delivery of biological kits and reagents, which are likely components of Emulate's organ-on-a-chip technology products used to model human biology. These products support the National Cancer Institute's initiatives in areas such as...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,616 purchase order to Emulate Inc., doing business as Emulate, located in Rockville, Maryland. The contract is for a one-year period starting December 20, 2023 through December 19, 2024 to provide a complete human emulation system as a service. No subcontractors or set aside designations were identified. The National Cancer Institute supports research to advance cancer prevention,...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated...
This firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) on June 1, 2020. The $130,163.45 contract, titled "EMULATE: ESTABLISHING ORGAN-CHIP MODELS FOR STUDYING RADIATION-INDUCED NORMAL TISSUE INJURY AND IDENTIFYING RNA BIOMARKERS FOR RADIATION BIODOSIMETRY," is for the development of an automated microfluidic cell culture system of human...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $96,829.63 firm-fixed-price purchase order to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies. The contract is for a Transcriptomics study - RNA-seq in Liver Spheroids Phase One, with the purpose of evaluating the safety and liver toxicity of candidate antisense oligonucleotides using a 3D liver microtissue...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order contract to Emulate, Inc., a for-profit organization, for $361,000.00. The contract is for Emulate's microfluidic-based microphysiological systems (MPS) assay platform to support NCATS' efficacy and toxicity/pharmacokinetics studies during drug discovery and development. The NCATS identified specific technical requirements for the MPS platform, including the use of a silicone polymer chip with a membrane, independent fluid flow control, and the ability to apply mechanical forces to recapitulate human physiology. This contract was not set aside for any specific business size or type.